Korean Exosome Skincare Brands Compared
By Dr. Mei Chen · Cosmetic Dermatologist & Senior Editor, The Exosome Edit
Updated Aug 2026- Exosomes are cell messengers that may help signal skin repair and renewal.
Disclosure: this article contains affiliate links — we may earn a commission on qualifying purchases at no extra cost to you.
Last updated: August 2026
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.
Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.
Quick Answer
- Exosomes are cell messengers that may help signal skin repair and renewal.
- Retail Korean brands ExoCoBio (ASCE+) and VT Cosmetics use plant, not stem-cell, exosomes.
- Professional-only Korean lines (ExoCoBio SRLV/HRLV, Korean-owned BENEV) sell through clinics only.
- No exosome product has FDA approval; a 2025 review found clinical evidence still lacking.
South Korea is the center of gravity for "exosome" skincare marketing, but the products sitting on Amazon shelves and the treatments administered inside a med spa are not the same category of product — and neither is human or animal exosome therapy, despite sharing the word "exosome" on the label. This article compares the real Korean brands behind the trend: ExoCoBio, whose ASCE+ line spans both a consumer serum and a professional clinical line; VT Cosmetics, a mainstream K-beauty brand that added exosome-branded ampoules and microneedling serums to its lineup; and BENEV, a US-based professional brand that became Korean-owned when ExoCoBio acquired it in 2023. We also look at what "exosome" actually means on an ingredient label, because the term gets used loosely across the category.
| Brand | Origin | Tier | Exosome source | Where to buy |
|---|---|---|---|---|
| ExoCoBio ASCE+ (retail) | Seongnam, South Korea | Consumer | Plant (Rosa damascena) | Amazon |
| ExoCoBio ASCE+ SRLV/HRLV | Seongnam, South Korea | Professional only | Plant (Rosa damascena) | Licensed clinics |
| VT Cosmetics Cica Exosome / Reedle Shot | Seoul, South Korea | Consumer | Plant (centella/cica) | Amazon, Korean retailers |
| BENEV Exosome Regenerative Complex | Mission Viejo, CA — Korean-owned since 2023 | Professional only | Plant (ExoCoBio-supplied) | Licensed clinics |
| The INKEY List Exosome Hydro-Glow (for comparison) | United Kingdom | Consumer | Plant (not disclosed by species) | Sephora, Amazon |
| Rion Aesthetics Plated (for comparison) | United States | Professional | Human (donor platelet-derived) | Licensed clinics |
What Are Exosomes and How Do They Work in Skincare?
Exosomes are microscopic vesicles that cells release to communicate with each other. They carry proteins, lipids, and RNA fragments, and when they reach a target cell, that cargo can influence how the cell behaves — including signals tied to tissue repair and collagen production. That's the biological basis for the "exosomes help skin heal and regenerate" claim that shows up across the category.
The Role of Exosomes as Cellular Messengers
Exosomes are small membrane-bound packages that cells use to send signals to other cells. In skincare marketing, exosomes are typically credited with stimulating collagen production, calming inflammation, and speeding recovery after in-office procedures like microneedling or laser treatments. The biology is real — cell-to-cell vesicle signaling is well established in research — but how much of that signaling survives when a vesicle is freeze-dried into a serum and applied topically is a separate, less-settled question from whether exosomes exist and function in a lab dish.
Plant-Derived vs. Human Stem-Cell Exosomes: The Distinction That Matters
This is where most of the confusion in "exosome skincare" starts. Human or animal stem-cell-derived exosomes are the kind used in early-stage clinical and cosmetic-injectable research, and they sit in a genuinely unsettled regulatory space — the U.S. FDA has not approved any exosome product and has sent warning letters to clinics marketing unapproved exosome injections. Plant-derived exosome-like vesicles are a different thing: they're extracellular vesicles isolated from plant cells (rose petals, broccoli, centella/cica) rather than from stem cells, and they're what most retail Korean "exosome" serums actually contain. Both ExoCoBio's consumer ASCE+ line and VT Cosmetics' Cica Exosome line are plant-derived — not human stem-cell-derived — which is a meaningfully different (and less regulated) ingredient category than what's used in clinical exosome therapy. Brands aren't always clear about this distinction in their marketing, so it's worth checking before assuming a serum works the same way an in-clinic treatment does.
Korean Exosome Skincare Brands Compared
ExoCoBio — ASCE+ (Retail and Professional Lines)
ExoCoBio is a Korean biotech company headquartered just south of Seoul, founded by CEO Byong Cho. It holds a U.S. patent on plant stem-cell-derived exosome technology and markets its ASCE+ line in two distinct tiers.
The retail tier, sold direct-to-consumer on Amazon, includes the ASCE+ Calming Ampoule Pro (a rose-exosome serum listed around $65–70) and the ASCE+ EXO Night Cream (a rose-exosome overnight cream around $50–55). Both use Rosa damascena (Damask rose) callus-derived plant exosomes and don't publish a specific protein or growth-factor count for the retail formula — a more conservative marketing approach than some competitors in the category.
The professional tier — ASCE+ SRLV and HRLV, sold only to licensed clinics, not consumers — is built on the same Rosa damascena plant-exosome platform but at a different concentration, marketed under ExoCoBio's "ExoSCRT" isolation technology, and its published spec sheet lists roughly 1,008 identified proteins and growth factors in the HRLV (hair-focused) formulation. That figure describes the professional clinical product, not the consumer serum on Amazon; treat any retail listing that borrows a professional-grade protein count for its own homepage copy with skepticism. ExoCoBio's own materials describe the company as one of the four largest exosome companies globally — a self-reported ranking worth noting as company marketing rather than an independently verified industry standing.
VT Cosmetics — Cica Exosome and Reedle Shot
VT Cosmetics is a Seoul-based K-beauty brand, originally launched in 2010 as an oral-care line under parent company Gonsen Inc. before expanding into skincare. Its "Cica Exosome" and "Reedle Shot" product lines are widely available on Amazon and at Korean beauty retailers.
VT's exosome ingredient, sold under its "VED" (VT Exosome Delivery) branding, is also plant-derived — purified centella (cica) extract processed into microscopic vesicles (VT's marketing cites a particle size around 141.9 nanometers) rather than human or animal stem-cell exosomes. The Reedle Shot line spans several concentrations — 100, 300, and 700 — combining this cica-exosome ingredient with spicule microneedling technology: tiny water-soluble mineral spicules meant to create temporary micro-channels that help topical ingredients absorb, which is a different mechanism from professional in-clinic microneedling with a motorized device.
VT also sells a PDRN Cica Exosome Ampoule (pairing the cica-exosome ingredient with polydeoxyribonucleotide, a salmon-DNA-derived healing ingredient popular in K-beauty), an Azelaic Acid Cica Exosome Ampoule aimed at brightening and blemish-prone skin, and a Cica-Exosome Moisture Mask sold in 20-sheet packs. Across the line, VT's marketing leans on the "exosome" branding for the delivery vesicle itself rather than making specific regenerative-medicine claims — a more measured framing than some clinical-adjacent competitors.
BENEV — Korean-Owned, Professional-Only
BENEV was founded in California in 2000 as a U.S. cosmeceutical and medical-device distributor — it isn't a Korean brand by origin. But in 2023, ExoCoBio acquired BENEV outright, making it Korean-owned. BENEV's Exosome Regenerative Complex is registered as a topical cosmetic in the U.S. and is KFDA-approved in Korea; it's applied by licensed practitioners after procedures like microneedling, laser treatment, or radiofrequency, not sold to consumers. Dr. Gideon Kwok, medical director of Skin Perfect Medical Aesthetics (founded 2004, now eight Southern California locations), is one of several physicians who sit on BENEV's professional advisory board alongside advisors for Galderma, Merz, HansBioMed, and Lutronic. Because it's a clinic-only product, there's no consumer Amazon listing to link to — if you've had "exosomes by BENEV" mentioned at a med spa, this is the company behind it.
Brands That Market "Exosome" Loosely
Not every "exosome" product on the shelf is Korean, and not every one is honest about what's inside. The INKEY List's $22 Exosome Hydro-Glow Complex (UK brand, sold at Sephora) is plant-derived and, notably, doesn't publish an exosome count or concentration claim at all — a reasonable approach given how unstandardized measurement is across the category. On the clinical end, Rion Aesthetics' Plated line uses platelet-derived exosomes (branded "Renewosome") sourced from purchased donor blood plasma, developed by Mayo Clinic-affiliated physicians — a genuinely different, human-derived source than the plant exosomes in most retail Korean serums. Neither is Korean, but both are useful reference points: a real ingredient can be marketed honestly (no inflated numbers) or less honestly (borrowed clinical-grade stats applied to a diluted retail formula), independent of country of origin.
What Does the Science Say About Exosomes in Dermatology?
The clinical evidence for exosomes in dermatology — plant-derived or otherwise — is still early. A 2025 review in the Journal of Clinical and Aesthetic Dermatology, "Exosomes: A Comprehensive Review for the Practicing Dermatologist" (Mahmoud RH, Peterson E, Badiavas EV, Kaminer M, Eber AE; J Clin Aesthet Dermatol. 2025;18(4):33–40; PMID: 40256340), is the most direct summary available. The authors write plainly: "Exosomes have demonstrated promise in preclinical models across various domains of aesthetic dermatology, including as anti-aging and anti-inflammatory therapies and as therapeutics for wound healing, scar reduction, and hair regeneration. However, clinical studies are lacking, and there are substantial safety concerns, such as the potential risk of infections, unwanted inflammatory response, and promotion of malignancy."
What the Preclinical Data Shows
In laboratory and animal models, exosomes have shown the ability to stimulate collagen production, reduce oxidative stress markers, and modulate inflammatory signaling — findings that underpin the anti-aging and wound-healing claims made across the category. The review notes this preclinical promise extends to scar reduction and hair regeneration as well. Preclinical results are a reasonable basis for continued research; they are not the same as demonstrated clinical benefit in human skin from a topical retail serum.
Why the Evidence Gap Matters for Consumers
The review's authors specifically call for more precise analytical techniques to characterize exosome composition and more rigorous clinical trials before exosome-based treatments can be recommended with confidence. That gap applies most directly to the professional/clinical tier — injectable or clinic-administered exosome products, where the safety concerns (infection risk, inflammatory response, theoretical malignancy risk) are most relevant. Retail plant-derived exosome serums sit in cosmetic regulation, not drug regulation, which lowers — but doesn't eliminate — the practical risk profile; it also means the FDA hasn't evaluated their efficacy claims at all.
What Are the Safety Concerns With Exosome Therapy?
Safety concerns differ meaningfully between the retail and professional tiers of this category, and conflating them is one of the more common mistakes in exosome skincare coverage.
Professional and Injectable Exosome Products
The FDA has not approved any exosome product for therapeutic use outside of a registered clinical trial. Between late 2024 and 2026, the agency issued warning letters to multiple clinics and manufacturers — including Chara Biologics, New Life Medical Services, and others — marketing unapproved exosome injections or infusions, citing reports of serious adverse events including infections and inflammatory reactions in patients treated with amniotic- or placental-derived exosome products. This is the regulatory territory the 2025 JCAD review's safety concerns are describing.
Retail Topical Exosome Serums
Plant-derived exosome serums like ASCE+'s consumer line and VT Cosmetics' Cica Exosome products are regulated as cosmetics, not drugs, in the U.S. — the same category as any other serum or moisturizer. That means lighter regulatory scrutiny and, correspondingly, a lower bar of evidence: a cosmetic doesn't have to prove a specific mechanism works to be sold, only that it's safe for topical use in the way any cosmetic must be. Formal safety incident data specific to plant-derived exosome cosmetics (as distinct from injectable stem-cell exosomes) is limited, largely because the ingredient category is new and hasn't been tracked separately in adverse-event reporting.
What This Means in Practice
If you're considering a professional exosome treatment — an injection, or an in-clinic topical applied after microneedling or laser — ask the practitioner directly what the product's regulatory status is and whether it's FDA-approved (it won't be, but a straight answer versus evasiveness is informative). If you're buying a retail serum, treat "exosome" on the label the way you'd treat "peptide" or "stem cell" — a real ingredient category with real variation in quality and honesty of marketing, not an automatic guarantee of the dramatic before-and-after results shown in a product's own marketing photos.
Which Korean Exosome Brand Fits Your Situation
If you want a retail serum to try at home: ExoCoBio's ASCE+ Calming Ampoule Pro and VT Cosmetics' Cica Exosome or Reedle Shot lines are the two verifiable, widely available options on Amazon. Both are plant-derived, both are regulated as ordinary cosmetics, and neither has published independent clinical trial data specific to the retail formula — treat them as well-formulated serums with an interesting delivery-vesicle ingredient, not as a substitute for an in-office treatment.
If you're comparing options after a professional procedure: BENEV's Exosome Regenerative Complex and ExoCoBio's professional ASCE+ SRLV/HRLV line are the two Korean-linked products most likely to show up on a med spa's treatment menu after microneedling, laser, or radiofrequency. Ask the practitioner which one they use, whether it's the plant-derived ExoCoBio platform (the more common answer) or a different source, and what specifically it's added to the procedure beyond the base treatment's own results — since the added benefit of any topical exosome step, plant- or otherwise, isn't yet backed by controlled clinical trials.
If a listing or clinic claims "human stem cell exosomes" in a product you can buy without a prescription or a licensed provider: that's worth double-checking. Direct-to-consumer human stem-cell exosome cosmetics would be operating in a regulatory gray zone at best; the verified Korean retail brands in this category (ExoCoBio, VT Cosmetics) are plant-derived specifically because that keeps them inside standard cosmetic regulation.
How to Read a Korean Exosome Skincare Label
Because "exosome" isn't a regulated or standardized term on a cosmetic label, three questions help separate a straightforward product from an oversold one.
Does It Say Where the Exosomes Come From?
A label or product page that specifies the source — "plant-derived," "Rosa damascena callus," "centella asiatica" — is giving you real, checkable information. A label that just says "exosome technology" without a source is leaning on the buzzword. Every retail Korean exosome product we could verify (ExoCoBio's ASCE+ consumer line, VT Cosmetics' Cica Exosome line) is plant-derived; none legally contains human stem-cell exosomes in a direct-to-consumer cosmetic, since that would put it in drug territory.
Does the Concentration Claim Mean Anything?
Numbers like "70,000ppm" or a specific exosome-particle count sound precise, but there's no industry-standard measurement protocol for exosome concentration in a finished cosmetic formula, so these figures aren't directly comparable brand-to-brand the way an SPF number is. Treat them as a marketing data point, not a lab-verified potency score.
Is the Product Being Sold for a Claim It Can't Legally Make?
Retail cosmetics can claim to hydrate, smooth, or improve the appearance of skin. They cannot legally claim to treat a medical condition, regenerate tissue, or reverse aging at a cellular level — those are drug claims. If a product listing reads more like a clinical case study than a cosmetics ad, that's worth noticing.
Frequently Asked Questions
What's the difference between ExoCoBio's retail and professional exosome products?
ExoCoBio's retail ASCE+ line (Calming Ampoule Pro, EXO Night Cream) is sold direct-to-consumer on Amazon and doesn't publish a specific protein count. Its professional ASCE+ SRLV/HRLV line is sold only to licensed clinics and carries a published spec of roughly 1,008 identified proteins and growth factors for the hair-focused HRLV formulation — a figure that describes the clinical product, not the consumer serum.
Is VT Cosmetics' Cica Exosome ingredient from human stem cells?
No. VT Cosmetics' Cica Exosome (branded "VED," VT Exosome Delivery) is derived from purified centella asiatica (cica) plant extract processed into microscopic vesicles, not from human or animal stem cells. This is true of most retail Korean exosome serums, including ExoCoBio's consumer line.
Is BENEV a Korean brand?
BENEV was founded in California in 2000 as a U.S. company. In 2023, Korean biotech company ExoCoBio acquired BENEV outright, making it Korean-owned, though it remains a U.S.-registered, clinic-only professional brand rather than a consumer retail line.
Are exosome skincare products FDA-approved?
No exosome product — plant-derived retail cosmetics or professional/injectable formulations — has FDA approval for therapeutic claims. Retail plant-exosome serums are regulated as cosmetics (the same category as any serum), while professional injectable exosome products have drawn FDA warning letters for unapproved marketing. A 2025 review in the Journal of Clinical and Aesthetic Dermatology found clinical trial evidence for exosomes in aesthetic use is still lacking.
Can exosome skincare be combined with microneedling?
Yes — this is the most common professional application. Microneedling creates micro-channels that increase absorption of topically applied ingredients, including exosome serums. VT Cosmetics' Reedle Shot line is built around this idea at the retail level, using mineral spicules rather than a professional microneedling device. For device-based protocols, see our 2026 exosome facials guide.
Related Reading
- Plant vs Human Exosomes: Which Work? (Compared)
- Exosome After Microneedling: Clinical Protocols
- Exosome Skincare: Complete Science Guide [2026]
- Ronan Exosome Skincare Review
- Stem Cell Skincare Safety Research Reviewed
— The The Exosome Edit Team